Stay updated on DUET Clinical Trial: Sparsentan in FSGS.
Sign up to get notified when there's something new on the DUET Clinical Trial: Sparsentan in FSGS. page.

Latest updates to the DUET Clinical Trial: Sparsentan in FSGS. page
- Check7 days agoChange Detected- Replaced v3.1.0 with v3.2.0 and added a government operations/status notice directing users to official sources. - No other substantive content changes detected.SummaryDifference3%
- Check15 days agoChange DetectedThe page has been updated to a new revision label (from v3.0.2 to v3.1.0), indicating a version bump without substantive content changes.SummaryDifference0.1%
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. No substantive content changes detected.SummaryDifference0.2%
- Check36 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, pricing, or availability.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated to include new drug information for Sparsentan, along with additional resources related to nephrotic syndrome and specific research articles. However, some previous information regarding Irbesartan and certain location details has been removed.SummaryDifference4%
- Check58 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to DUET Clinical Trial: Sparsentan in FSGS.
Enter your email address, and we'll notify you when there's something new on the DUET Clinical Trial: Sparsentan in FSGS. page.